Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1965 2
1979 7
1980 10
1981 8
1982 12
1983 12
1984 14
1985 22
1986 26
1987 30
1988 26
1989 32
1990 27
1991 40
1992 62
1993 55
1994 69
1995 87
1996 85
1997 104
1998 125
1999 112
2000 159
2001 178
2002 214
2003 241
2004 328
2005 431
2006 503
2007 530
2008 740
2009 830
2010 906
2011 1126
2012 1285
2013 1624
2014 1883
2015 2129
2016 2196
2017 2347
2018 2671
2019 2999
2020 3586
2021 2924
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

27,636 results
Results by year
Filters applied: . Clear all
Page 1
Global prevalence and major risk factors of diabetic retinopathy.
Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, Chen SJ, Dekker JM, Fletcher A, Grauslund J, Haffner S, Hamman RF, Ikram MK, Kayama T, Klein BE, Klein R, Krishnaiah S, Mayurasakorn K, O'Hare JP, Orchard TJ, Porta M, Rema M, Roy MS, Sharma T, Shaw J, Taylor H, Tielsch JM, Varma R, Wang JJ, Wang N, West S, Xu L, Yasuda M, Zhang X, Mitchell P, Wong TY; Meta-Analysis for Eye Disease (META-EYE) Study Group. Yau JW, et al. Among authors: xu l. Diabetes Care. 2012 Mar;35(3):556-64. doi: 10.2337/dc11-1909. Epub 2012 Feb 1. Diabetes Care. 2012. PMID: 22301125 Free PMC article. Review.
Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II-IIIA (N1-N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study.
Zhong WZ, Wang Q, Mao WM, Xu ST, Wu L, Shen Y, Liu YY, Chen C, Cheng Y, Xu L, Wang J, Fei K, Li XF, Li J, Huang C, Liu ZD, Xu S, Chen KN, Xu SD, Liu LX, Yu P, Wang BH, Ma HT, Yan HH, Yang XN, Zhou Q, Wu YL; ADJUVANT investigators. Zhong WZ, et al. Among authors: xu l. Lancet Oncol. 2018 Jan;19(1):139-148. doi: 10.1016/S1470-2045(17)30729-5. Epub 2017 Nov 21. Lancet Oncol. 2018. PMID: 29174310 Clinical Trial.
Ten Years of EWAS.
Wei S, Tao J, Xu J, Chen X, Wang Z, Zhang N, Zuo L, Jia Z, Chen H, Sun H, Yan Y, Zhang M, Lv H, Kong F, Duan L, Ma Y, Liao M, Xu L, Feng R, Liu G, Project TE, Jiang Y. Wei S, et al. Among authors: xu l. Adv Sci (Weinh). 2021 Aug 11:e2100727. doi: 10.1002/advs.202100727. Online ahead of print. Adv Sci (Weinh). 2021. PMID: 34382344 Review.
Engineering of chiral nanomaterials for biomimetic catalysis.
Zhang H, Li S, Qu A, Hao C, Sun M, Xu L, Xu C, Kuang H. Zhang H, et al. Among authors: xu l. Chem Sci. 2020 Oct 21;11(48):12937-12954. doi: 10.1039/d0sc03245j. Chem Sci. 2020. PMID: 34094483 Free PMC article. Review.
Low dimensional materials for glucose sensing.
Xu L, Zhang X, Wang Z, Haidry AA, Yao Z, Haque E, Wang Y, Li G, Daeneke T, McConville CF, Kalantar-Zadeh K, Zavabeti A. Xu L, et al. Nanoscale. 2021 Jul 1;13(25):11017-11040. doi: 10.1039/d1nr02529e. Nanoscale. 2021. PMID: 34152349 Review.
The Roles of MicroRNAs in Tendon Healing and Regeneration.
Ding L, Wang M, Qin S, Xu L. Ding L, et al. Among authors: xu l. Front Cell Dev Biol. 2021 Jul 2;9:687117. doi: 10.3389/fcell.2021.687117. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34277629 Free PMC article. Review.
27,636 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page